AbCellera Biologics (ABCL) Revenue (2020 - 2026)
AbCellera Biologics (ABCL) posted Revenue of $8.3 million for Q1 2026, down 81.46% on a QoQ basis from $44.9 million in Q4 2025, and up 96.34% year-over-year from $4.2 million in Q1 2025.
AbCellera Biologics (ABCL) Revenue (2020 - 2026) Analysis & Trends
AbCellera Biologics' Revenue history runs 7 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- Quarterly Revenue rose 96.34% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.2 million (up 242.66% YoY) and the FY2025 annual result came in at $75.1 million, up 160.56% from the prior year.
- Revenue was $8.3 million for Q1 2026 at AbCellera Biologics, down from $44.9 million in the prior quarter.
- Across five years, Revenue topped out at $316.6 million in Q1 2022 and bottomed at $4.2 million in Q1 2025.
- A 5-year average of $37.4 million and a median of $10.0 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue surged 1740.65% — and 2023, when it tumbled 96.15%.
- AbCellera Biologics' Revenue stood at $21.5 million in 2022, then sank by 57.4% to $9.2 million in 2023, then tumbled by 44.98% to $5.0 million in 2024, then soared by 788.18% to $44.9 million in 2025, then slumped by 81.46% to $8.3 million in 2026.
- Business Quant data shows ABCL's Revenue at $8.3 million in Q1 2026, $44.9 million in Q4 2025, and $9.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | 8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.32 Mn |
| Dec 31, 2025 | 44.85 Mn |
| Sep 30, 2025 | 8.96 Mn |
| Jun 30, 2025 | 17.08 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Sep 30, 2024 | 6.51 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 9.95 Mn |
| Dec 31, 2023 | 9.18 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 10.06 Mn |
| Mar 31, 2023 | 12.19 Mn |
| Dec 31, 2022 | 21.55 Mn |
| Sep 30, 2022 | 101.38 Mn |
| Jun 30, 2022 | 45.92 Mn |
| Mar 31, 2022 | 316.58 Mn |
| Dec 31, 2021 | 139.33 Mn |
| Sep 30, 2021 | 5.51 Mn |
| Jun 30, 2021 | 27.64 Mn |